Literature DB >> 22918878

Mice harboring Gnrhr E90K, a mutation that causes protein misfolding and hypogonadotropic hypogonadism in humans, exhibit testis size reduction and ovulation failure.

M David Stewart1, Jian Ming Deng, C Allison Stewart, Rachael D Mullen, Ying Wang, Suhujey Lopez, M Katalina Serna, Cheng-Chiu Huang, Jo Ann Janovick, Andrew J Pask, Robert J Schwartz, P Michael Conn, Richard R Behringer.   

Abstract

GnRH, produced in the hypothalamus, acts on pituitary gonadotropes to stimulate release of the gonadotropins LH and FSH. Reduced responsiveness of gonadotropes to GnRH is a primary cause of hypogonadotropic hypogonadism (HH), a disease characterized by gonadal dysfunction and low blood levels of gonadotropins. Loss-of-function mutations in the gene encoding the receptor for GnRH (GNRHR) are a common cause of HH. Sequencing of the GNRHR gene in patients with HH revealed mainly point mutations producing single amino acid substitutions that cause misfolding and misrouting of this G protein-coupled receptor. To generate a mouse model that mimics the human disease, we introduced a single amino acid substitution (E90K) into the mouse Gnrhr gene, which is identical to a known human recessive mutation. In humans, E90K causes severe HH by preventing formation of the E90-K121 salt bridge, which is essential for correct folding. In cell cultures, E90K causes misfolding that leads to almost complete retention by the protein quality control system and subsequent degradation. Here we report that the primary phenotype of mice homozygous for E90K is female infertility due to ovulation failure. Mutant males are fertile despite reduced gonadotropin levels and smaller testes. These results suggest decreased GnRH receptor signaling in the mutant animal, compared with wild type. Our findings suggest that a threshold level of GnRH receptor activity is required for ovulation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22918878      PMCID: PMC3487620          DOI: 10.1210/me.2012-1072

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  29 in total

1.  A pulsatile gonadotropin-releasing hormone stimulus is required to increase transcription of the gonadotropin subunit genes: evidence for differential regulation of transcription by pulse frequency in vivo.

Authors:  D J Haisenleder; A C Dalkin; G A Ortolano; J C Marshall; M A Shupnik
Journal:  Endocrinology       Date:  1991-01       Impact factor: 4.736

2.  Differential effects of gonadotropin-releasing hormone (GnRH) pulse frequency on gonadotropin subunit and GnRH receptor messenger ribonucleic acid levels in vitro.

Authors:  U B Kaiser; A Jakubowiak; A Steinberger; W W Chin
Journal:  Endocrinology       Date:  1997-03       Impact factor: 4.736

3.  Gonadotropin and gonadal steroid release in response to a gonadotropin-releasing hormone agonist in Gqalpha and G11alpha knockout mice.

Authors:  D Stanislaus; J A Janovick; T Ji; T M Wilkie; S Offermanns; P M Conn
Journal:  Endocrinology       Date:  1998-06       Impact factor: 4.736

4.  Klinefelter's syndrome in Sardinia. Clinical report of 265 hypogonadic males detected at the time of military check-up.

Authors:  G Filippi
Journal:  Clin Genet       Date:  1986-10       Impact factor: 4.438

5.  Regulation of the rat pituitary gonadotropin-releasing hormone receptor.

Authors:  J Marian; R L Cooper; P M Conn
Journal:  Mol Pharmacol       Date:  1981-05       Impact factor: 4.436

6.  Human loss-of-function gonadotropin-releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum: molecular basis of the dominant-negative effect.

Authors:  Shaun P Brothers; Anda Cornea; Jo Ann Janovick; P Michael Conn
Journal:  Mol Endocrinol       Date:  2004-04-22

7.  Identification and characterization of the gonadotropin-releasing hormone response elements in the mouse gonadotropin-releasing hormone receptor gene.

Authors:  E R Norwitz; G R Cardona; K H Jeong; W W Chin
Journal:  J Biol Chem       Date:  1999-01-08       Impact factor: 5.157

Review 8.  Clinical and molecular genetics of the human GnRH receptor.

Authors:  Beate Karges; Wolfram Karges; Nicolas de Roux
Journal:  Hum Reprod Update       Date:  2003 Nov-Dec       Impact factor: 15.610

9.  Isolation and characterization of the 5'-flanking region of the mouse gonadotropin-releasing hormone receptor gene.

Authors:  C T Albarracin; U B Kaiser; W W Chin
Journal:  Endocrinology       Date:  1994-12       Impact factor: 4.736

10.  A mechanism for the differential regulation of gonadotropin subunit gene expression by gonadotropin-releasing hormone.

Authors:  U B Kaiser; E Sabbagh; R A Katzenellenbogen; P M Conn; W W Chin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

View more
  10 in total

Review 1.  Mutations in G protein-coupled receptors that impact receptor trafficking and reproductive function.

Authors:  Alfredo Ulloa-Aguirre; Teresa Zariñán; James A Dias; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2013-06-24       Impact factor: 4.102

2.  "Been hit twice": a novel bi-allelic heterozygous mutation in LHCGR.

Authors:  T Rajendra Kumar
Journal:  J Assist Reprod Genet       Date:  2014-07       Impact factor: 3.412

Review 3.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

4.  Fertility and fragrance: another cause of Kallmann syndrome.

Authors:  Shlomo Melmed
Journal:  J Clin Invest       Date:  2015-05-18       Impact factor: 14.808

5.  Chronic Estrus Disrupts Uterine Gland Development and Homeostasis.

Authors:  C Allison Stewart; M David Stewart; Ying Wang; Rachel D Mullen; Bonnie K Kircher; Rui Liang; Yu Liu; Richard R Behringer
Journal:  Endocrinology       Date:  2022-03-01       Impact factor: 4.736

6.  Restoration of testis function in hypogonadotropic hypogonadal mice harboring a misfolded GnRHR mutant by pharmacoperone drug therapy.

Authors:  Jo Ann Janovick; M David Stewart; Darla Jacob; L D Martin; Jian Min Deng; C Allison Stewart; Ying Wang; Anda Cornea; Lakshmi Chavali; Suhujey Lopez; Shoukhrat Mitalipov; Eunju Kang; Hyo-Sang Lee; Pulak R Manna; Douglas M Stocco; Richard R Behringer; P Michael Conn
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

Review 7.  Transitioning pharmacoperones to therapeutic use: in vivo proof-of-principle and design of high throughput screens.

Authors:  P Michael Conn; David C Smithson; Peter S Hodder; M David Stewart; Richard R Behringer; Emery Smith; Alfredo Ulloa-Aguirre; Jo Ann Janovick
Journal:  Pharmacol Res       Date:  2013-12-25       Impact factor: 7.658

8.  Gonadotropin-releasing hormone receptor (Gnrhr) gene knock out: Normal growth and development of sensory, motor and spatial orientation behavior but altered metabolism in neonatal and prepubertal mice.

Authors:  Ellen R Busby; Nancy M Sherwood
Journal:  PLoS One       Date:  2017-03-27       Impact factor: 3.240

Review 9.  Misfolded G Protein-Coupled Receptors and Endocrine Disease. Molecular Mechanisms and Therapeutic Prospects.

Authors:  Alfredo Ulloa-Aguirre; Teresa Zariñán; Eduardo Jardón-Valadez
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

Review 10.  Targeting trafficking as a therapeutic avenue for misfolded GPCRs leading to endocrine diseases.

Authors:  Alfredo Ulloa-Aguirre; Teresa Zariñán; Rubén Gutiérrez-Sagal; Ya-Xiong Tao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-25       Impact factor: 6.055

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.